The CGP utilizes advanced technologies like next-generation sequencing to analyze cancer genomes. The process involves collecting tissue samples from cancer patients, extracting DNA, and sequencing it to identify mutations. These data are then compared to a reference genome to pinpoint specific genetic alterations.
